Literature DB >> 22155408

Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells.

Lokman Varisli1, Ceren Gonen-Korkmaz, Hamid Muhammad Syed, Nuray Bogurcu, Bilge Debelec-Butuner, Burcu Erbaykent-Tepedelen, Kemal Sami Korkmaz.   

Abstract

We recently reported that hematological and neurological expressed 1 (HN1) is a ubiquitously expressed, EGF-regulated gene. Expression of HN1 in prostate cell lines down-regulates PI3K-dependent Akt activation. Here, we investigate whether HN1 is regulated by androgens through the putative androgen response elements (AREs) found in its promoter. Knockdown of HN1 expression by siRNA silencing leads to an increase in Akt((S473)) phosphorylation, resulting in the translocation of androgen receptor (AR) to the nucleus; these effects can be abrogated by the non-specific Akt inhibitor LY294002 but not by the ERK inhibitor PD98059. Furthermore, HN1 overexpression correlates with an increase in ubiquitination-mediated degradation (a consequence of the decrease in S213/210 phosphorylation of AR), ultimately resulting in the down-regulation of AR-mediated expression of the KLK3, KLK4, NKX3.1 and STAMP2 genes. We also found that HN1 overexpression suppresses colony formation as well as R1881-mediated growth in LNCaP cells, while it has the opposite effect (increasing colony formation but not proliferation) in PC-3 and DU145 cells. Therefore, we suggest that HN1 maintains a balance between the androgen-regulated nuclear translocation of AR and steady-state Akt phosphorylation, predominantly in the absence of androgens. If so, the balance between cell growth and EGF- and AR-signaling must be tightly regulated by HN1. This work has important implications for prostate cancer research, as AR, EGFR and HN1 are known to be highly expressed in prostate adenocarcinomas.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155408     DOI: 10.1016/j.mce.2011.11.027

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  14 in total

1.  Decreased expression of EFS is correlated with the advanced prostate cancer.

Authors:  Selda Sertkaya; Syed Muhammad Hamid; Nihat Dilsiz; Lokman Varisli
Journal:  Tumour Biol       Date:  2014-10-09

2.  METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A/HN1L positive feedback circuit.

Authors:  Qiong Wu; Qingqing Hu; Yanan Hai; Yandong Li; Yong Gao
Journal:  J Cell Commun Signal       Date:  2022-08-04       Impact factor: 5.908

Review 3.  Androgen receptor phosphorylation: biological context and functional consequences.

Authors:  Yulia Koryakina; Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-01-14       Impact factor: 5.678

4.  Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer.

Authors:  Lei Li; Ting-Ting Zeng; Bao-Zhu Zhang; Yan Li; Ying-Hui Zhu; Xin-Yuan Guan
Journal:  Cancer Biol Ther       Date:  2017-10-20       Impact factor: 4.742

5.  HN1 interacts with γ-tubulin to regulate centrosomes in advanced prostate cancer cells.

Authors:  Lokman Varisli; Aadil Javed; Bilge Esin Ozturk; Gencer Kaan Akyuz; Gulevin Takir; Fani-Marlen Roumelioti; Sarantis Gagos; Kutsal Yorukoglu; Kemal Sami Korkmaz
Journal:  Cell Cycle       Date:  2021-08-12       Impact factor: 5.173

6.  New transcriptional-based insights into the pathogenesis of desmoplastic small round cell tumors (DSRCTs).

Authors:  Tiziana Negri; Silvia Brich; Fabio Bozzi; Chiara V Volpi; Ambra V Gualeni; Silvia Stacchiotti; Loris De Cecco; Silvana Canevari; Annunziata Gloghini; Silvana Pilotti
Journal:  Oncotarget       Date:  2017-05-16

7.  Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer.

Authors:  H Alexander Ebhardt; Alex Root; Chris Sander; Ruedi Aebersold; Yansheng Liu; Nicholas Paul Gauthier
Journal:  NPJ Syst Biol Appl       Date:  2018-07-02

8.  HNRNPA1-mediated 3' UTR length changes of HN1 contributes to cancer- and senescence-associated phenotypes.

Authors:  Qi Jia; Hongbo Nie; Peng Yu; Baiyun Xie; Chenji Wang; Fu Yang; Gang Wei; Ting Ni
Journal:  Aging (Albany NY)       Date:  2019-06-30       Impact factor: 5.682

9.  Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.

Authors:  Nicholas W Bateman; Pang-Ning Teng; Erica Hope; Brian L Hood; Julie Oliver; Wei Ao; Ming Zhou; Guisong Wang; Domenic Tommarello; Katlin Wilson; Tracy Litzy; Kelly A Conrads; Chad A Hamilton; Kathleen M Darcy; Yovanni Casablanca; George Larry Maxwell; Victoria Bae-Jump; Thomas P Conrads
Journal:  Cancer Med       Date:  2019-12-06       Impact factor: 4.452

Review 10.  Targeted Radionuclide Therapy of Prostate Cancer-From Basic Research to Clinical Perspectives.

Authors:  Malwina Czerwińska; Aleksander Bilewicz; Marcin Kruszewski; Aneta Wegierek-Ciuk; Anna Lankoff
Journal:  Molecules       Date:  2020-04-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.